Abstract: The present invention relates to a delivery system which includes a bioactive drug or cosmetic substance presented in the form of submicron oil spheres alone, or drugs or cosmetic substances in a combination with the oil spheres in an aqueous suspension or emulsion. Optionally, a skin penetration enhancer may be included in such formulations. Such preparations achieve improved bioavailability and exert larger pharmacological effects than an equivalent dose of the drug or cosmetic formulated in conventional creams, lotions or oleaginous bases.

Abstract: A stable non-alcoholic cosmetic composition containing 13-trans retinal which is an oil-in-water emulsion in which the fatty phase constituents have a peroxide number no greater than about 5, and in which the fatty phase includes 10-15% by weight of capric/caprylic triglycerides and 0.02-0.5% by weight of the antioxidant BHT, and method of making the same.

Abstract: The invention relates to a stable multiple phase emulsion of the O.sub.1 /W/O.sub.2 type with high proportions of the primary O.sub.1 /W emulsion. The new emulsions have an emulsifier-free primary oil-in-water phase consisting of a viscoplastic aqueous gel containing the finely distributed inner oil droplets together with a gelling agent, wherein the thixotropic primary oil-in-water phase has a yield point in the range from 20 to 100 Pa and a plastic viscosity of 0.01 to 0.1 Pa.multidot.s and contains at least one lipophilic agent in the primary oil; and a secondary oil phase in which the primary oil-in-water phase is present together with a lipophilic emulsifier; and wherein the proportion of the inner oily phase is from 10 to 35 % by weight relative to the total weight of the emulsion. The higher proportions of the inner oily phase render possible higher proportions of organic sun protection agents with simultaneous avoidance of skin irritations.

Abstract: Stable, topically applicable oil-in-water bioaffecting emulsions having intermediate viscosity, characteristically ranging from 3 to 10 Pa.multidot.s, comprise (a) from 30% to 50% by weight of at least one pro-penetrating glycol, (b) at least one emulsifying agent, advantageously an anionic amphiphilic polymer, and (c) at least one biologically active agent, for example an active agent that modulates skin differentiation and/or proliferation and/or pigmentation, an anti-inflammatory, an antibacterial, an antifungal, etc.

Abstract: A heat and shelf-stable oil-in-water emulsion useful as a tissue or cell-selective delivery vehicle. Radioactive or stable, synthetic or semi-synthetic polyhalogenated triglycerides, such as 2-oleoylglycerol-1,3-bis[7-(3-amino-2,4,6-triiodophenyl)heptanoate] or 2-oleoylglycerol-1,3-bis[.omega.-(3,5-bis-trifluoromethyl)-heptanoate] or phenyl acetate, can be incorporated into the lipophilic core of a lipoprotein-like emulsion particle. The lipophilic core is surrounded by a phospholipid membrane comprising cholesterol and apolipoproteins. For hepatocyte-selective delivery, the emulsion is chylomicron remnant-like by being in a size range of 50 to 200 nm as measured by number weighting analysis with a narrow size distribution (<2% greater than 300 nm) and having a composition simulating naturally-occurring chylomicron remnants. Use of cholesterol in the emulsion formula facilitates association of apolipoproteins, especially Apo E which are recognized by liver cells and necessary for binding and uptake.

Abstract: A composition which is a cream or lotion for topical application to human skin. The composition includes emu oil as a component. Emu oil is generally comprised of myristic acid, palmitic acid, palmitoleic acid, margaric acid, stearic acid, elaidic acid, oleic acid, vaccenic acid, linoleic acid, linolenic acid, arachidic acid and eicosenoic acid. The composition also includes a medically active component, such as lactic acid or some other alpha-hydroxy acid. The balance of the components of the composition are water, glycerin, and an emulsion base. Liposomes may be included in the composition. The composition provides for increased skin penetrability due to the emu oil.

Abstract: A composition and delivery system are disclosed that will allow feverfew to be administered to a person in form in which an active ingredient of feverfew, particularly parthenolide can be readily and quickly assimilated by the person's body, particularly the central nervous system, and the therapeutic effects of the feverfew be rapidly imparted to the person. Feverfew is administered in the form of aqueous nasal spray composition, to provide therapeutic moisturization of nasal mucous membranes, relief of migraine headaches and antispasmodic effect, such as to relieve menstrual cramping or aid digestion. The effect is enhanced when the composition also contains nanoclustered resonant water. Vitamins, vitamin derivatives, surfactants, wetting agents, preservatives and emulsifiers may also be present.

Abstract: A dispersion for carrying at least one water-soluble material or water-dispersible material (especially ascorbic acid, Vitamin C) in a relatively stable form is described, the dispersion comprising an oil phase containing particles comprising water-soluble polymer, water-soluble material or water-dispersible material (ascorbic acid), and water. The dispersion preferably comprises particles which have number average diameter dimensions of less than 2 microns, more preferably less than 1 micron. The dispersion may comprise oil components such as, for example only, a mineral oil, silicone oil, or cosmetic oil. A method of forming a dispersion of solid particles which comprise water-soluble material or water-dispersible material (e.g.

Abstract: The present invention relates to a W/O emulsion comprising cross-linked, water-swellable polymers consisting ofa) 35-100% by weight of ionic monomers,b) 0-65% by weight of non-ionic monomers,c) 0.3-1 mol-%, based on a) and b), of one or more at least bifunctional monomer.The oil phase of the W/O emulsion consists of polyglycerol fatty acid esters and comprises at least one fatty acid ester of diglycerol or triglycerol with caprylic or capric acid. The W/O emulsions are usefull as thickeners for cosmetic or pharmaceutical compositions.

Abstract: Formulations of intravenous anesthetic propofol emulsions are provided which contain sufficiently low concentrations of soybean oil to produce a stable emulsion and simultaneously provide reduced nutrients, which inhibit microbial growth thereby providing protection against accidental microbial contamination during long-term IV infusions. In addition to the inhibition of microbial growth due to a reduction of nutrients, the formulation exhibits unanticipated additional microbial inhibition due to an increased availability of propofol. The low concentration of soybean oil also provides a formulation that reduces the chances of fat overload when administered over an extended period of time to chronically ill patients.

Abstract: Topically applicable sunscreen/cosmetic compositions well suited for enhanced photoprotection of human skin and/or hair against the damaging effects of UV-A and UV-B irradiation, particularly solar radiation, comprise (i) a photoprotecting effective amount of 2,4,6-tris[p-((2'-ethylhexyl)oxycarbonyl)anilino]-1,3,5-triazine and (ii) at least one homomenthyl and/or octyl salicylate solvent for the triazine sunscreen compound (i), in a cosmetically acceptable vehicle, diluent or carrier therefor.

Abstract: A skin care composition in the form of an oil-in-water dispersion includes, by weight:a) from about 0.1% to about 20% of a silicone component comprising a silicone gum having a molecular weight of from about 200,000 to about 4,000,000;b) from about 2% to about 10% of an emulsifier capable of forming liquid crystals in water and comprising sucrose fatty acid ester and sorbitan fatty acid ester; andc) humectant;wherein at least a portion of the humectant is in the form of an admixture with a particulate carrier material, the weight ratio of humectant to carrier is from about 1:4 to about 3:1, and the particulate carrier is a cross-linked polymethacrylate copolymer.

Abstract: A method is disclosed for controlling biofouling in an aqueous medium by treating the aqueous medium with an oil-in-water emulsion comprising an antimicrobial oil phase and at least one emulsifier. This method efficiently controls biofouling in the aqueous medium by specifically targeting the antimicrobial oil phase directly to biofilms, cell surfaces and cell aggregates in a concentrated form.

Abstract: The small particle liposome or lipid complex aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes or other lipid complexes. The liposomes and complexes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.

Abstract: Process for the preparation of oil-in-water creams comprising the steps ofI forming a low-viscosity, very fine particle oil-in-water emulsion by heating the following composition to a temperature within or above its phase inversion temperature range:A) 1 part by weight of liquid oil component,B) from about 0.1 to about 0.5 parts by weight of at least one nonionic emulsifier having an HLB value of from 11 to 15,C) from about 0.1 to about 0.2 parts by weight of at least one co-emulsifier selected from saturated fatty alcohols containing 16 to 22 carbon atoms and partial esters of polyols containing 3 to 6 carbon atoms with saturated fatty acids containing 143 to 22 carbon atoms, andD) from about 1 to about 6 parts by weight of water; andII thickening the emulsion from step I to the consistency of a cream by adding thereto at least one consistency generator selected from co-emulsifiers defined in step I C) above and water-soluble polymers, wherein the thickened emulsion exhibits plastic behavior at 20.degree. C.

Abstract: This composition based on polyglycosides comprises 30 to 65% by weight of at least one fatty alcohol of formula ROH, where R is a staturated or unsaturated, straight-chained or branched aliphatic radical having 1 to 4 ethylenically unsaturated bonds and having 12 to 22 carbon atoms, the remainder being a mixture of polyglycosides containing 35 to 75% by weight, based on the polyglycosides, of polyhexosides.

Abstract: A skin care composition comprising an oil-in-water emulsion and a therapeutically effective amount of a retinoid selected from the group consisting of Vitamin A alcohol, Vitamin A aldehyde, retinyl acetate, retinyl palmitate and mixtures thereof, the composition having a pH of between about 4 and about 10 and further comprising an oil phase comprising one or more oils having a total unsaturation density, or C value, of about 1200 or less.

Abstract: Methods for preparing dry powders having hydrophobic and hydrophilic components comprise combining solutions of the components and spray drying them simultaneously in a spray dryer. The hydrophilic and hydrophobic component are separately dissolved in separate solvents and directed simultaneously through a nozzle, usually a coaxial nozzle, into the spray dryer. The method provides dry powders having relatively uniform characteristics.

Abstract: An oil-in-water emulsified composition comprising an a .alpha.-monoalkyl glyceryl ether, a wax, and a silicone oil: wherein the amount of the silicone oil is not less than 10 wt % with respect to an oil phase except the a .alpha.-monoalkyl glyceryl ether and the wax, this composition displays excellent emulsion stability and feeling of use.

Abstract: A classical method of microemulsion formation involves mixing an oil and water with a surfactant (S1), and a co-surfactant (S2). The oil is mostly preferably a cyclic siloxane. The oil is added to a solution of the surfactant (S1) and water. A two-phase system containing the siloxane results. The two-phase system is then titrated with co-surfactant (S2) until a clear isotropic microemulsion results. An emulsion polymerization catalyst is added to the clear isotropic microemulsion, and polymerization of the cyclic siloxane is initiated. The polimerization is allowed to advance until the reaction is complete, or desired degree of polymerization (DP) has been obtained. Microemulsions of high molecular weight silicone polymers with low polydispersity can be produced.

Abstract: This invention relates to compositions, compounds and methods for lightening skin, using active compounds having the structure: ##STR1## wherein: (i) each X is, independently, selected from the group consisting of halo, alkyl, substituted alkyl, aryl, OR, OCOR, COR, CONRR COOR, CN, SR, SOR, SO.sub.2 R, SO.sub.3 R and NRR, wherein X is other than hydroxy, amino and thio, if this X is attached ortho to the phenol hydroxy;(ii) m is an integer from 0 to 4;(iii) each R' and each R" is, independently, selected from the group consisting of hydrogen, halo, alkyl, substituted alkyl, aryl, OR, OCOR, OCRROR, COR, CR(OR)OR, CONRR, COOR, CRROR, CN, SR, and NRR; wherein halo, when it appears, is other than geminal to a hydroxy, NH.sub.

Abstract: The present invention relates to a cosmetic or dermatological composition comprising an emulsion of oil-in-water type formed of oily globules which are each provided with a lamellar liquid crystal coating and are dispersed in an aqueous phase. Each oily globule containing at least one lipophilic compound which is cosmetically or dermatologically active is individually coated with a monolamellar or oligolamellar layer obtained from at least one lipophilic surface-active agent, from at least one hydrophilic surface-active agent and from at least one ionic amphiphilic lipid imparting to the emulsion a pH ranging from 5.5 to 7.5, the coated oily globules having a mean diameter of less than 500 nanometers.

Abstract: This invention is to provide a fine dispersion composition of wax which is stable in wide temperature range and is favorable in safety such as skin irritation, and is to provide a hair cosmetic preparation which is excellent in hair dressing power and has less stickiness and can give smoothness and easiness of combing to a hair, and to provide a glazing agent. A fine dispersion composition and a hair cosmetic preparation and a glazing agent comprising the same which comprises amphoteric surfactant and/or semi-polar surfactant, nonionic surfactant and wax, a hair cosmetic preparation which comprises said fine dispersion composition of wax and one or more of a specific effective ingredient, and a glazing agent which comprises said fine dispersion composition of wax.

Abstract: The present invent is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of cyclosporin in association with a pharmaceutical carrier, said carrier comprising a drug solubilizing effective amount of a fatty acid having 6-22 carbon atoms and a non-ionic surfactant.

Abstract: A medical lubricant suitable for injection into the blood stream of a patient. The lubricant is suitable for use with rotating equipment such as atherectomy drive shafts moving within sheaths and over guide wires. The lubricant is an oil-in-water emulsion including a surfactant and a co-surfactant. The lubricant can include a cryogenic agent and a pH buffer and be pH adjusted. One lubricant includes olive oil as an emulsified oil, egg yolk phospholipid as a surfactant, sodium deoxycholate as a co-surfactant, glycerin as a cryogenic agent, L-histidine as a pH buffer, and is pH adjusted using sodium hydroxide. The lubricant can withstand freeze/thaw cycles as well as saline dilution, heating, and shear stress without significant creaming, separation, or unacceptable increases in oil droplet size. Compared to saline, the lubricant provides significantly increased lubrication efficiency for rapidly moving parts.

Abstract: The subject-matter of the invention is a cosmetic composition comprising, in a cosmetically acceptable medium, at least phloroglucinol or one of its derivatives. Another subject-matter of the invention is the use of phloroglucinol or of its derivatives in a cosmetic composition intended to promote epidermal renewal.

Abstract: A thickener for products for topical application such as personal care products for application to the skin or hair, or topically administrable pharmaceutical preparations, comprises a water-in-oil emulsion containing polymeric material, at least 98% of which polymeric material is soluble in the aqueous phase. The polymeric material comprises units derived from (a) acrylamide, (b) 2-acrylamido-2-methylpropane-sulphonic acid (AMPS) and (c) a polyfunctional monomer, present in an amount of from 0.12 to 2 milliequivalents per mol of total monomer units. At least some of the AMPS units are in the form of a neutral salt such that the aqueous phase of the water in oil emulsion has a pH of at least 5.5.

Abstract: The present invention relates to a wax-based composition comprising at least about 0.5-30% water in a water-in-oil emulsion, wherein water is encapsulated in a lamellar lipid vesicle capable of withstanding wax melting point temperatures. The composition is useful in delivering water soluble actives in an anhydrous base, and is particularly well-adapted for uses in lipsticks and lip-care products.

Abstract: An oil-in-water emulsion, the oil globules of which have a mean size of less than 150 nm, comprising an amphiphilic lipid phase containing at least one non-ionic amphiphilic lipid which is liquid at an ambient temperature of less than 45.degree. C. and at least one cationic amphiphilic lipid, and its uses in cosmetics or in dermopharmaceuticals.

Abstract: Disclosed is a method of producing microspheres which comprises subjecting a w/o/w emulsion or o/w emulsion to an in-water drying method under the following conditions:1) the amount of microspheres per m.sup.3 of an external aqueous phase is about 0.1 to about 500 kg,2) the square root of the area (unit: m.sup.2) of the liquid surface in contact with the gas phase is about 0.2 to about 4.5 per the cube root of the volume (unit: m.sup.3) of an external aqueous phase,3) the w/o/w emulsion or o/w emulsion is replaced at the replacement frequency of about 0.01 to about 10 times/minutes,4) a gas is blown to the w/o/w emulsion or o/w emulsion at the gas transfer rate near the liquid surface of about 0.1 to about 300 m/second, and5) the gas is replaced at the replacement frequency of not less than about 0.5 times/minutes;and the method of the present invention increases the rate of solvent removal from microspheres in in-water drying, reduces the amount of solvent in microspheres in a short time.

Abstract: A self-foaming composition in the form of a post-foaming, pressurizable oil-in-water emulsion comprising:(A) at least 5% by weight, relative to the total weight of the composition, of a fatty phase comprising at least one cosmetic oil,(B) a gelling system comprising at least one emulsifying polymer which is selected from the group consisting of:(1) crosslinked homopolymers formed from at least one cationic or anionic monomer containing ethylenic unsaturation selected from the group consisting of ammonium (meth)acrylate; 2-acrylamido-2-methylpropanesulfonic acid as well as its salts, dialkylaminoalkyl (meth)acrylates, dialkylaminoalkyl (meth)acrylamide and its quaternary salts or acids, wherein the crosslinking agent which forms the crosslinking contains ethylenic polyunsaturation, and(2) crosslinked copolymers formed from at least one cationic or anionic monomer containing ethylenic unsaturation, from at least one nonionic comonomer and from a crosslinking agent containing ethylenic polyunsaturation; and(C) w

Abstract: Disclosed herein are microemulsion insecticides that do not contain conventional actives. The microemulsion form permits insects to be killed by an oil/surfactant combination.

Abstract: The invention relates to an antisun composition with a high degree of protection, containing water-soluble and liposoluble screening agents, combined with a solid elastomeric organopolysiloxane, which has noteworthy cosmetic properties. It is in the form of a water-in-oil or oil-in-water emulsion. The invention also relates to a process for protecting the skin or the lips against solar radiation, containing this composition.

Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 -alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.

Abstract: The invention relates to cosmetic compositions of improved rinsability, comprising an oily phase and a citric acid ester corresponding to formula (I): ##STR1## in which R.sub.1, R.sub.2 and R.sub.3, which may be identical or different, represent a hydrogen atom, an alkali metal or alkaline-earth metal, an ammonium cation or a cation of an organic base or a group of formula (II):--(C.sub.n H.sub.2n --O).sub.m --R.sub.4 (II)with n=2, 3 or 4m=5-30and R.sub.4 represents a saturated, linear or branched C.sub.8 -C.sub.24 alkyl group, at least one of R.sub.1, R.sub.2 and R.sub.3 being a group of formula (II). These compositions are used in particular for cleansing and/or removing make-up from the skin.

Abstract: Cosmetic skin care compositions containing 4-chromanone. The inventive compositions improve barrier function of the skin.

Abstract: Methods for inactivating bacteria including bacterial spores using an oil-in-water emulsion are provided. The oil-in-water emulsion comprises an oil, a surfactant and an organic phosphate-based solvent. These methods can be used to inactivate a wide variety of bacteria such as Bacillus.

Abstract: A clear single phase composition contains 40-95% by weight of a cyclic or short chain linear methyl siloxane and water, and 5-60% by weight of a cationic surfactant and a nonionic surfactant. The cyclic or short chain linear methyl siloxane in the single phase composition has an average structure or droplet diameter of less than about 50 nanometer. The single phase composition spontaneously provides optically clear one phase silicone microemulsions when combined with only hand agitation. The clear single phase compositions are useful in personal care and textile applications.

Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.

Abstract: Cosmetic skin care compositions containing succinate compounds and cosmetic method of improving the appearance of wrinkled, lined, dry, flaky, aged or photodamaged skin and improving skin thickness, elasticity, flexibility, radiance, glow and plumpness.

Abstract: The subject of the invention is new cosmetic compositions, based on pigment nanoparticles and on fillers, which are completely transparent and free from whitening when they are applied on the skin, which possess sufficient UV screening properties for the addition of organic screening agents to be unnecessary, which are better dispersed than the compositions of the prior art and which are outstandingly stable. These compositions, when they are used in makeup, exhibit greater homogeneity of the colour and a colouring which is both transparent and more intense. The present invention also relates to methods of imparting these improved properties to makeup compositions.

Abstract: The present invention relates to a delivery system which includes a bioactive drug or cosmetic substance presented in the form of submicron oil spheres alone, or drugs or cosmetic substances in a combination with the oil spheres in an aqueous suspension or emulsion. Optionally, a skin penetration enhancer may be included in such formulations. Such preparations achieve improved bioavailability and exert larger pharmacological effects than an equivalent dose of the drug or cosmetic formulated in conventional creams, lotions or oleaginous bases.

Abstract: Topically applicable sunscreen/cosmetic compositions well suited for enhanced photoprotection of human skin and/or hair against the damaging effects of UV-A and UV-B irradiation, particularly solar radiation, comprise a photoprotecting effective amount of a novel sulfonamido-functional polyorganosiloxane/polyorganosilane having one of the formulae (1) to (3): ##STR1## wherein A is a monovalent benzylidenecamphor radical which comprises a sulfonamido-functional bridging group, which is bonded directly to a silicon atom, and which has the formula. (4.

Abstract: A pharmaceutical composition containing a microemulsion made up of a hydrophilic component, a lipophilic component, a surfactant and a drug, where the hydrophilic component, the lipophilic component and the surfactant form, when examined on a macroscopic scale, a one-phase solution. The hydrophilic component is dispersed as colloidal droplets in the lipophilic component, or the lipophilic component is dispersed as colloidal droplets in the hydrophilic component. According to still another alternative, the hydrophilic and the lipophilic components form a microemulsion with bicontinuous structure where the components form elongated adjacent channels. The drug is dissolved in the dispersed component or, in the case of a microemulsion with bicontinuous structure, in the hydrophilic or the lipophilic component. The microemulsion is stabilized by means of the surfactant. It is characteristic that a gelatinizer and water are added to the microemulsion thereby bringing the microemulsion into a gel form.

Abstract: The present invention relates to the preparation of therapeutic compositions comprising extracts of leguminous plants from which the isoflavones genistein, daidzein, formononetin and biochanin and/or their glycosides have been removed. The invention also relates to therapeutic uses of such extracts in the treatment, prophylaxis, amelioration of, or defense against a variety of cancers.

Abstract: Oil-in-water type emulsions having a pH below or equal to 3.5, especially a pH below or equal to 3, and comprising as a stabilizing agent a substantially water-soluble crosslinked anionic copolymer consisting of units derived from the reaction between (i) acrylamide, (ii) 2-acrylamido-2-methylpropanesulfonic acid and (iii) at least one compound possessing multiple olefinic unsaturation (crosslinking agent), in which the compound possessing multiple olefinic unsaturation is present in the copolymer at a concentration of between 0.06 and 1 mmol per mole of the collective monomer units, are stable.

Abstract: A sprayable or solid biodegradable wax carrier for insect pheromones and a method for constant release rate of the pheromone from the biodegradable wax. A composition comprising a pheromone and paraffin wax formulated as an aqueous emulsion or a solid suitable for application to a surface of a tree or crop for mating disruption of insect pests. Pheromone is released by diffusion or by partitioning from the biodegradable wax carrier or by pheromone exposure due to the biodegradable wax carrier degradation.

Abstract: Disclosed are topical compositions which provide good coverage of skin imperfections, e.g., pores and uneven skin tone, while retaining a natural skin appearance. The compositions contain a particulate material having a refractive index of at least about 2, e.g., TiO.sub.2, and a skin conditioning component.

Abstract: Methods for preparing dry powders having hydrophobic and hydrophilic components comprise combining solutions or suspensions of the components and spray drying them simultaneously in a spray drier. The hydrophilic component is dissolved in an aqueous solution and the hydrophobic component suspended therein. The method provides dry powders having relatively uniform characteristics.

Abstract: Disclosed are topical compositions which provide good coverage of skin imperfections, e.g., pores and uneven skin tone, while retaining a natural skin appearance. The compositions contain a charged particulate material dispersed throughout a thickened, hydrophilic carrier. The charged particulate material allows the compositions to have a Coverage Efficiency Ratio of greater than about 20.